Transforming Growth Factor β (TGF-β)-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF-β Function

REFERENCES

• Aberle, H., H. Schwartz, and R. Kemler. 1996. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell. Biochem. 61:514–523.
   PubMed Web of Science ®Google Scholar
• Alonso, A., J. Sasin, N. Bottini, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699–711.
   PubMed Web of Science ®Google Scholar
• Andersen, J. N., O. H. Mortensen, G. H. Peters, P. G. Drake, L. F. Iversen, O. H. Olsen, P. G. Jansen, H. S. Andersen, N. K. Tonks, and N. P. Moller. 2001. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21:7117–7136.
   PubMed Web of Science ®Google Scholar
• Angers-Loustau, A., J. F. Cote, and M. L. Tremblay. 1999. Roles of protein tyrosine phosphatases in cell migration and adhesion. Biochem. Cell Biol. 77:493–505.
   PubMedGoogle Scholar
• Ardini, E., R. Agresti, E. Tagliabue, M. Greco, P. Aiello, L. T. Yang, S. Menard, and J. Sap. 2000. Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo. Oncogene 19:4979–4987.
   PubMed Web of Science ®Google Scholar
• Bakin, A. V., C. Rinehart, A. K. Tomlinson, and C. L. Arteaga. 2002. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115:3193–3206.
   PubMed Web of Science ®Google Scholar
• Brandt, D. T., A. Goerke, M. Heuer, M. Gimona, M. Leitges, E. Kremmer, R. Lammers, H. Haller, and H. Mischak. 2003. Protein kinase C delta induces Src kinase activity via activation of the protein tyrosine phosphatase PTP alpha. J. Biol. Chem. 278:34073–34078.
   PubMed Web of Science ®Google Scholar
• Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
   PubMed Web of Science ®Google Scholar
• Coffey, R. J., Jr., N. J. Sipes, C. C. Bascom, R. Graves-Deal, C. Y. Pennington, B. E. Weissman, and H. L. Moses. 1988. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res. 48:1596–1602.
   PubMedGoogle Scholar
• Cong, L. N., H. Chen, Y. Li, C. H. Lin, J. Sap, and M. J. Quon. 1999. Overexpression of protein tyrosine phosphatase-alpha (PTP-alpha) but not PTP-kappa inhibits translocation of GLUT4 in rat adipose cells. Biochem. Biophys. Res. Commun. 255:200–207.
   PubMedGoogle Scholar
• Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:117–129.
   PubMed Web of Science ®Google Scholar
• Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584.
   PubMed Web of Science ®Google Scholar
• Dumont, N., A. V. Bakin, and C. L. Arteaga. 2003. Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. J. Biol. Chem. 278:3275–3285.
   PubMedGoogle Scholar
• Fuchs, M., T. Muller, M. M. Lerch, and A. Ullrich. 1996. Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J. Biol. Chem. 271:16712–16719.
   PubMedGoogle Scholar
• Fujii, M., K. Takeda, T. Imamura, H. Aoki, T. K. Sampath, S. Enomoto, M. Kawabata, M. Kato, H. Ichijo, and K. Miyazono. 1999. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10:3801–3813.
   PubMed Web of Science ®Google Scholar
• Gobbi, H., W. D. Dupont, J. F. Simpson, W. D. Plummer, Jr., P. A. Schuyler, S. J. Olson, C. L. Arteaga, and D. L. Page. 1999. Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J. Natl. Cancer Inst. 91:2096–2101.
   PubMedGoogle Scholar
• Goggins, M., M. Shekher, K. Turnacioglu, C. J. Yeo, R. H. Hruban, and S. E. Kern. 1998. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res. 58:5329–5332.
   PubMed Web of Science ®Google Scholar
• Granot-Attas, S., and A. Elson. 2004. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells. Exp. Cell Res. 294:236–243.
   PubMedGoogle Scholar
• Hahn, S. A., M. Schutte, A. T. Hoque, C. A. Moskaluk, L. T. da Costa, E. Rozenblum, C. L. Weinstein, A. Fischer, C. J. Yeo, R. H. Hruban, and S. E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353.
   PubMed Web of Science ®Google Scholar
• Jiang, Y. P., H. Wang, P. D'Eustachio, J. M. Musacchio, J. Schlessinger, and J. Sap. 1993. Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region. Mol. Cell. Biol. 13:2942–2951.
   PubMed Web of Science ®Google Scholar
• Liu, F., M. A. Sells, and J. Chernoff. 1998. Transformation suppression by protein tyrosine phosphatase 1B requires a functional SH3 ligand. Mol. Cell. Biol. 18:250–259.
   PubMedGoogle Scholar
• Lorenz, U., A. D. Bergemann, H. N. Steinberg, J. G. Flanagan, X. Li, S. J. Galli, and B. G. Neel. 1996. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J. Exp. Med. 184:1111–1126.
   PubMed Web of Science ®Google Scholar
• Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, et al. 1995. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338.
   PubMed Web of Science ®Google Scholar
• Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753–791.
   PubMed Web of Science ®Google Scholar
• Massague, J., and Y. G. Chen. 2000. Controlling TGF-beta signaling. Genes Dev. 14:627–644.
   PubMed Web of Science ®Google Scholar
• Mauro, L. J., and J. E. Dixon. 1994. ‘Zip codes’ direct intracellular protein tyrosine phosphatases to the correct cellular ‘address’. Trends Biochem. Sci. 19:151–155.
   PubMed Web of Science ®Google Scholar
• Moghal, N., and P. W. Sternberg. 1999. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr. Opin. Cell Biol. 11:190–196.
   PubMed Web of Science ®Google Scholar
• Moses, H. L., E. L. Branum, J. A. Proper, and R. A. Robinson. 1981. Transforming growth factor production by chemically transformed cells. Cancer Res. 41:2842–2848.
   PubMed Web of Science ®Google Scholar
• Moulder, S. L., F. M. Yakes, S. K. Muthuswamy, R. Bianco, J. F. Simpson, and C. L. Arteaga. 2001. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Cancer Res. 61:8887–8895.
   PubMed Web of Science ®Google Scholar
• Muraoka, R. S., N. Dumont, C. A. Ritter, T. C. Dugger, D. M. Brantley, J. Chen, E. Easterly, L. R. Roebuck, S. Ryan, P. J. Gotwals, V. Koteliansky, and C. L. Arteaga. 2002. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Investig. 109:1551–1559.
   PubMed Web of Science ®Google Scholar
• Muraoka, R. S., Y. Koh, L. R. Roebuck, M. E. Sanders, D. Brantley-Sieders, A. E. Gorska, H. L. Moses, and C. L. Arteaga. 2003. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor β1. Mol. Cell. Biol. 23:8691–8703.
   PubMed Web of Science ®Google Scholar
• Muraoka-Cook, R. S., H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga. 2004. Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 64:9002–9011.
   PubMed Web of Science ®Google Scholar
• Nakamura, M., M. Kishi, T. Sakaki, H. Hashimoto, H. Nakase, K. Shimada, E. Ishida, and N. Konishi. 2003. Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. Cancer Res. 63:737–741.
   PubMedGoogle Scholar
• Oliff, A., M. D. McKinney, and O. Agranovsky. 1985. Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus. J. Virol. 54:864–868.
   PubMedGoogle Scholar
• Parsons, S. J., and J. T. Parsons. 2004. Src family kinases, key regulators of signal transduction. Oncogene 23:7906–7909.
   PubMed Web of Science ®Google Scholar
• Ren, X. D., W. B. Kiosses, D. J. Sieg, C. A. Otey, D. D. Schlaepfer, and M. A. Schwartz. 2000. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J. Cell Sci. 113:3673–3678.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn. 1985. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119–123.
   PubMed Web of Science ®Google Scholar
• Russell, W. E., R. J. Coffey, Jr., A. J. Ouellette, and H. L. Moses. 1988. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85:5126–5130.
   PubMed Web of Science ®Google Scholar
• Sap, J., Y. P. Jiang, D. Friedlander, M. Grumet, and J. Schlessinger. 1994. Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding. Mol. Cell. Biol. 14:1–9.
   PubMed Web of Science ®Google Scholar
• Schoenwaelder, S. M., and K. Burridge. 1999. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell Biol. 11:274–286.
   PubMed Web of Science ®Google Scholar
• Seton-Rogers, S. E., Y. Lu, L. M. Hines, M. Koundinya, J. LaBaer, S. K. Muthuswamy, and J. S. Brugge. 2004. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 101:1257–1262.
   PubMed Web of Science ®Google Scholar
• Shin, D. Y., T. Ishibashi, T. S. Choi, E. Chung, I. Y. Chung, S. A. Aaronson, and D. P. Bottaro. 1997. A novel human ERK phosphatase regulates H-ras and v-raf signal transduction. Oncogene 14:2633–2639.
   PubMedGoogle Scholar
• Siegel, P. M., W. Shu, R. D. Cardiff, W. J. Muller, and J. Massague. 2003. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100:8430–8435.
   PubMed Web of Science ®Google Scholar
• Su, J., A. Batzer, and J. Sap. 1994. Receptor tyrosine phosphatase R-PTP-alpha is tyrosine-phosphorylated and associated with the adaptor protein Grb2. J. Biol. Chem. 269:18731–18734.
   PubMedGoogle Scholar
• Thannickal, V. J., D. Y. Lee, E. S. White, Z. Cui, J. M. Larios, R. Chacon, J. C. Horowitz, R. M. Day, and P. E. Thomas. 2003. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278:12384–12389.
   PubMed Web of Science ®Google Scholar
• Tucker, R. F., G. D. Shipley, H. L. Moses, and R. W. Holley. 1984. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 226:705–707.
   PubMed Web of Science ®Google Scholar
• Ueda, Y., S. Wang, N. Dumont, J. Y. Yi, Y. Koh, and C. L. Arteaga. 2004. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks TGF-induced cell motility. J. Biol. Chem. 279:24505–24513.
   PubMed Web of Science ®Google Scholar
• Wakefield, L. M., and A. B. Roberts. 2002. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12:22–29.
   PubMed Web of Science ®Google Scholar
• Wang, D., T. Kanuma, H. Mizunuma, F. Takama, Y. Ibuki, N. Wake, A. Mogi, Y. Shitara, and S. Takenoshita. 2000. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Cancer Res. 60:4507–4512.
   PubMed Web of Science ®Google Scholar
• Wang, H., V. Radjendirane, K. K. Wary, and S. Chakrabarty. 2004. Transforming growth factor beta regulates cell-cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 23:5558–5561.
   PubMedGoogle Scholar
• Wang, J., L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J. K. Willson, et al. 1995. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270:22044–22049.
   PubMed Web of Science ®Google Scholar
• Wiener, J. R., S. K. Kassim, Y. Yu, G. B. Mills, and R. C. Bast, Jr. 1996. Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression. Gynecol. Oncol. 61:233–240.
   PubMedGoogle Scholar
• Wieser, R., J. L. Wrana, and J. Massague. 1995. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J. 14:2199–2208.
   PubMedGoogle Scholar
• Yakes, F. M., W. Chinratanalab, C. A. Ritter, W. King, S. Seelig, and C. L. Arteaga. 2002. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res. 62:4132–4141.
   PubMed Web of Science ®Google Scholar
• Yang, Y., M. Gil, S. M. Byun, I. Choi, K. H. Pyun, and H. Ha. 1996. Transforming growth factor-beta1 inhibits human keratinocyte proliferation by upregulation of a receptor-type tyrosine phosphatase R-PTP-kappa gene expression. Biochem. Biophys. Res. Commun. 228:807–812.
   PubMedGoogle Scholar
• Yang, Y., M. C. Gil, E. Y. Choi, S. H. Park, K. H. Pyun, and H. Ha. 1997. Molecular cloning and chromosomal localization of a human gene homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase. Gene 186:77–82.
   PubMedGoogle Scholar
• Yang, Y. A., O. Dukhanina, B. Tang, M. Mamura, J. J. Letterio, J. MacGregor, S. C. Patel, S. Khozin, Z. Y. Liu, J. Green, M. R. Anver, G. Merlino, and L. M. Wakefield. 2002. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Investig. 109:1607–1615.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and M. X. Sliwkowski. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:127–137.
   PubMed Web of Science ®Google Scholar
• Yu, X., S. Miyamoto, and E. Mekada. 2000. Integrin alpha 2 beta 1-dependent EGF receptor activation at cell-cell contact sites. J. Cell Sci. 113:2139–2147.
   PubMed Web of Science ®Google Scholar
• Zeng, L., X. Si, W. P. Yu, H. T. Le, K. P. Ng, R. M. Teng, K. Ryan, D. Z. Wang, S. Ponniah, and C. J. Pallen. 2003. PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration. J. Cell Biol. 160:137–146.
   PubMedGoogle Scholar
• Zhai, J., H. Lin, Z. Nie, J. Wu, R. Canete-Soler, W. W. Schlaepfer, and D. D. Schlaepfer. 2003. Direct interaction of focal adhesion kinase with p190RhoGEF. J. Biol. Chem. 278:24865–24873.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., R. Siebert, P. Matthiesen, Y. Yang, H. Ha, and B. Schlegelberger. 1998. Cytogenetical assignment and physical mapping of the human R-PTP-kappa gene (PTPRK) to the putative tumor suppressor gene region 6q22.2-q22.3. Genomics 51:309–311.
   PubMedGoogle Scholar